Ann: EuGeni Test Strip Manufacturing Strategy, page-40

Interesting perspective.

I am a most cynical of persons, and am also a long term shareholder but I have to say that my view of the past year in ADO is almost completely the opposite of yours.

I think the speed that the board has managed to pivot this company from pure research to verging on manufacturing is commendable. The situation since the pandemic began has been extremely fluid, and yet they have managed to steer through some very complex approvals and continue moving in a direction which has looked well conceived, well timed and efficient.

From my point of view, kudos to the board and indeed the management for an ongoing project which has taken the company from the depths for shareholders to approaching true success.